API
API

Cilostazol, Cilostazol API, Chongqing Kangle, US DMF 25666, Japan PMDA, Korea MFDS, Russia Registered, CAS No. 73963-72-1

Cilostazol, Cilostazol API, Chongqing Kangle, US DMF 25666, Japan PMDA, Korea MFDS, Russia Registered, CAS No. 73963-72-1
Product Summary

Original Manufacturer: Chongqing Kangle Pharmaceutical Co., Ltd.Chinese Approval No.: H20040578 (API) CEP: Not Available FDA Inspection Status: VAI (September 2025) Standard: JP / USP Disclaimer: All detailed product information shall be subject to the issued final COA. US DMF Letters of Authorizati...

Product Description
Detailed Specifications & Features

Original Manufacturer: Chongqing Kangle Pharmaceutical Co., Ltd.
Chinese Approval No.: H20040578 (API) 
CEP: Not Available 
FDA Inspection Status: VAI (September 2025) 
Standard: JP / USP

Disclaimer: All detailed product information shall be subject to the issued final COA. US DMF Letters of Authorization (LOA) and regional registration documentation are available to qualified buyers upon request. Please contact us with your target market and required pharmacopoeial grade.